Data / Research funding / Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth Disease: 64 NIH awards ($56.1M) to 36 organizations

Name: NIH and NSF awards on Charcot-Marie-Tooth Disease
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

64 NIH awards ($56.1M) in the NIH spending category Charcot-Marie-Tooth Disease, to 36 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Charcot-Marie-Tooth Disease Watch Charcot-Marie-Tooth Disease

Topic: NIH spending category

Awards

64 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$4,141,654	December 15, 2017	November 30, 2026	LUPSKI, JAMES R.	reporter.nih.gov
Accelerate Clinical Trials in CMT (ACTCMT) Study	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$3,658,507	May 1, 2019	February 28, 2026	HERRMANN, DAVID N	reporter.nih.gov
Exploring the Functions of tRNA Synthetases in the Nucleus and their Relationship to CMT	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$2,285,535	April 1, 2020	March 31, 2025	YANG, XIANG-LEI	reporter.nih.gov
Link extracellular function of tRNA synthetase with pathological mechanism of disease	NIH	National Institute of General Medical Sciences	2021 to 2025	$2,260,000	June 1, 2021	August 31, 2026	YANG, XIANG-LEI	reporter.nih.gov
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$2,243,240	January 1, 2021	December 31, 2025	VAN DER BLIEK, ALEXANDER M	reporter.nih.gov
The Genetics of the Neuromuscular Junction: Mechanisms and Disease Models	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$2,053,330	August 1, 2025	May 31, 2027	BURGESS, ROBERT W.	reporter.nih.gov
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$1,960,976	September 30, 2019	August 31, 2024	DORN, GERALD W.	reporter.nih.gov
Mitofusin Agonists to Treat Neurodegenerative Disease	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$1,954,883	May 15, 2022	April 30, 2025	HAUGER, DEBORAH ANN	reporter.nih.gov
Genomic Studies in Charcot-Marie-Tooth Disease	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,886,243	September 15, 2019	July 31, 2025	ZUCHNER, STEPHAN	reporter.nih.gov
Allele-specific inactivation for dominant negative NEFL Mutations	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$1,855,975	August 15, 2021	June 30, 2027	JUDGE, LUKE M	reporter.nih.gov
Folding, Misfolding, and Function of PMP22	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$1,650,616	April 1, 2016	January 31, 2028	SANDERS, CHARLES R	reporter.nih.gov
JAX-Gladstone, SCGE Disease Models Studies Supplement	NIH	National Institute of Environmental Health Sciences	2021 to 2022	$1,641,672	September 25, 2018	June 30, 2023	CONKLIN, BRUCE R	reporter.nih.gov
Impact of Schwann Cell Pathology on Axon Structure and Function	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$1,574,423	December 1, 2022	November 30, 2027	SALZER, JAMES	reporter.nih.gov
Laminin Receptors and Signals in Schwann Cells	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,546,694	July 1, 2003	January 31, 2025	SIM, FRASER JAMES	reporter.nih.gov
Functional Analysis of O-GlcNAc using Synthetic Protein Chemistry	NIH	National Institute of General Medical Sciences	2021 to 2024	$1,442,331	August 1, 2015	July 31, 2025	PRATT, MATTHEW ROBERT	reporter.nih.gov
Generalizing genome editing for rare disease-causing variants	NIH	Office of the Director, National Institutes of Health	2025	$1,416,375	September 18, 2025	August 31, 2028	NEWBY, GREGORY A.	reporter.nih.gov
Novel SMARD1 Mouse Models: Characterization and Evaluation of Potential Therapeutic Targets	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,380,377	February 1, 2020	January 31, 2026	LORSON, CHRISTIAN L.	reporter.nih.gov
The Role of ESCRTs in Regulating Nervous System Function	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,306,650	December 1, 2019	November 30, 2025	WILSON, SCOTT MICHAEL	reporter.nih.gov
Translational control of stress response signaling	NIH	National Institute of General Medical Sciences	2023 to 2025	$1,286,370	September 22, 2023	August 31, 2028	RYOO, HYUNG D	reporter.nih.gov
Understanding the role of patient-derived Ighmbp2 mutations in neurodegeneration and pre-rRNA processing	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$1,181,939	January 1, 2024	December 31, 2028	LORSON, CHRISTIAN L.	reporter.nih.gov
Comprehensive gene and DNA variant curation for neuromuscular diseases	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,079,672	June 15, 2021	May 31, 2025	ZUCHNER, STEPHAN	reporter.nih.gov
Role of a Fatty Acid Chaperone in Schwann Cell Myelination	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$1,019,124	February 1, 2024	January 31, 2029	BELIN, SOPHIE	reporter.nih.gov
Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$887,500	January 1, 2021	March 31, 2024	YANG, XIANG-LEI	reporter.nih.gov
tRNA Gene Replacement Therapy for tRNA-Synthetase Related Charcot-Marie-Tooth Disorder	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$841,280	July 1, 2024	March 31, 2027	BURGESS, ROBERT W.	reporter.nih.gov
Pathogenesis in Segmental Demyelination	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$804,961	June 1, 2023	May 31, 2028	HU, BO	reporter.nih.gov
Small Molecule Tools for Modulating Membrane Rafts	NIH	National Institute of General Medical Sciences	2021 to 2022	$764,342	September 1, 2020	August 31, 2024	KENWORTHY, ANNE K	reporter.nih.gov
A Novel Pharmacologic Approach to Treat CMT1X	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$751,688	September 15, 2020	August 31, 2024	DOBROWSKY, RICK T	reporter.nih.gov
Structural Biology of Connexin Membrane Channels	NIH	National Institute of General Medical Sciences	2022 to 2023	$705,371	July 1, 2020	June 30, 2025	YEAGER, MARK JAY	reporter.nih.gov
Structural Biology of Connexin Membrane Channels	NIH	National Institute of General Medical Sciences	2021 to 2022	$693,855	July 1, 2020	October 31, 2022	YEAGER, MARK JAY	reporter.nih.gov
Molecular mechanisms underlying mitochondria-lysosome membrane contact sites in neuronal function and neurodegeneration	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$633,556	September 30, 2018	November 30, 2023	WONG, YVETTE	reporter.nih.gov
Charcot-Marie-Tooth Disease Type 2E: Mechanism and therapy	NIH	National Institute of Neurological Disorders and Stroke	2025	$499,452	May 15, 2025	April 30, 2030	BROWN, ANTHONY	reporter.nih.gov
Function and Regulation of PMP22 in CMT1A and HNPP	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$481,950	September 21, 2021	March 31, 2024	MOSS, KATHRYN RENAE	reporter.nih.gov
Dissecting the Integrated Stress Response in tRNA Synthetase-Associated Neuropathies	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2024	$481,875	March 1, 2023	February 28, 2025	BURGESS, ROBERT W.	reporter.nih.gov
Function and Regulation of PMP22 in CMT1A and HNPP	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$469,902	September 21, 2021	March 31, 2027	MOSS, KATHRYN RENAE	reporter.nih.gov
The impact of ITPR3 mutations on immunity	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$451,000	June 21, 2024	April 30, 2027	VAN OERS, NICOLAI STANISLAS CYRILLE	reporter.nih.gov
Characterizing Tissue Specific Regulation of Mutant Lamin Protein Degradation	NIH	National Institute on Aging	2021	$442,936	July 1, 2016	August 30, 2025	HAMMOND, THOMAS MICHAEL	reporter.nih.gov
Targeting the PMP22 Protein to Develop Leads Against Charcot-Marie-Tooth Disease	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$435,441	January 20, 2021	December 31, 2022	SANDERS, CHARLES R	reporter.nih.gov
Restoring neurofilaments to axons in a mouse model of CMT2E	NIH	National Institute of Neurological Disorders and Stroke	2021	$433,125	September 15, 2021	February 29, 2024	BROWN, ANTHONY	reporter.nih.gov
Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D	NIH	National Institute of Neurological Disorders and Stroke	2021	$431,350	January 1, 2021	December 31, 2021	YANG, XIANG-LEI	reporter.nih.gov
Exploring a new arm of the integrated stress response and its connection to neurodegeneration	NIH	National Institute of Neurological Disorders and Stroke	2021	$410,563	July 1, 2021	December 31, 2022	YANG, XIANG-LEI	reporter.nih.gov
Creation of a Schwann Cell Gene Regulatory Network	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$400,985	March 1, 2022	February 28, 2025	SVAREN, JOHN P	reporter.nih.gov
Pathogenesis in Segmental Demyelination	NIH	National Institute of Neurological Disorders and Stroke	2022	$385,000	July 15, 2022	July 17, 2022	HU, BO	reporter.nih.gov
Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology	NIH	National Cancer Institute	2021	$363,713	September 18, 2017	August 31, 2022	STAFF, NATHAN P	reporter.nih.gov
TISSUE ENGINEERED HUMAN NEUROMUSCULAR JUNCTIONS FOR MODELING AXONAL NEUROPATHY	NIH	National Institute of Neurological Disorders and Stroke	2021	$356,426	November 15, 2016	October 31, 2023	KIM, DEOK-HO	reporter.nih.gov
Fibroblast-derived Engineered Extracellular Vesicle (FieEV) Technology for Targeted Delivery of RNA Therapeutics to treat CMT1A Diseases	NIH	National Center for Advancing Translational Sciences	2025	$350,000	August 15, 2025	August 14, 2026	DUARTE SANMIGUEL, SILVIA M.	reporter.nih.gov
MRI Biomarkers of Disease Progression in Inherited Neuropathies	NIH	National Center for Advancing Translational Sciences	2021 to 2022	$286,885	April 1, 2021	July 11, 2022	LI, JUN	reporter.nih.gov
Development of novel ASO-based therapeutics for CMT1A	NIH	National Institute of Neurological Disorders and Stroke	2022	$256,580	June 1, 2022	May 31, 2023	OCONNOR, STEVE	reporter.nih.gov
Understanding the Role of the Integrated Stress Response in tRNA Synthetase-associated Charcot-Marie-Tooth Disease	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2024	$244,402	August 1, 2023	July 31, 2025	HINES, TIMOTHY	reporter.nih.gov
Pathogenesis of TRPV4-related peripheral neuropathy	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$244,178	September 15, 2018	June 30, 2023	MCCRAY, BRETT ANDREW	reporter.nih.gov
Longitudinal Changes in Gait and Ankle Function in Youth with Charcot-Marie-Tooth Disease	NIH	National Institute of Neurological Disorders and Stroke	2023	$186,250	September 21, 2023	August 31, 2025	WREN, TISHYA A L	reporter.nih.gov
Testing SARM1 as a Therapeutic Target in Multiple Forms of Charcot-Marie-Tooth Disease	NIH	National Institute of Neurological Disorders and Stroke	2022	$173,100	August 1, 2022	July 31, 2024	BURGESS, ROBERT W.	reporter.nih.gov
Exploring the Pathophysiology of CMT1G	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$163,500	March 1, 2024	February 28, 2027	BELIN, SOPHIE	reporter.nih.gov
Mechanisms of Neurodegeneration in CMT4B3: a Complex Pediatric Neurodevelopmental Disorder	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2025	$161,206	August 1, 2023	July 31, 2027	JACOBS, ELIZABETH HALEY	reporter.nih.gov
Structure of GDAP1 bound to a product of lipid peroxidation	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2024	$144,326	March 1, 2023	February 28, 2026	VANDEMARK, ANDREW PAUL	reporter.nih.gov
Production and evaluation CMT2 mouse models of ATP1A1 loss-of-function-mutation using Cre-LoxP technology	NIH	National Institute of Neurological Disorders and Stroke	2021	$136,941	April 1, 2021	January 31, 2022	ARTIGAS, PABLO	reporter.nih.gov
Actin-mediated regulation of organelle dynamics in Charcot-Marie-Tooth disease	NIH	National Institute of General Medical Sciences	2021 to 2022	$136,192	January 1, 2021	December 31, 2022	SCHIAVON, CARA RAE	reporter.nih.gov
Exploring the Role of OSM-9 in Odor Aversive Learning and Long-term Memory	NIH	National Institute on Deafness and Other Communication Disorders	2021 to 2023	$126,637	September 1, 2021	August 31, 2024	SAIFUDDIN, MASHEL FATEMA	reporter.nih.gov
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7	NIH	National Institute on Aging	2023 to 2025	$102,738	April 1, 2023	June 2, 2025	MULLIGAN, RYAN J	reporter.nih.gov
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE	NIH	National Institute of Neurological Disorders and Stroke	2021	$78,500	March 15, 2021	July 31, 2021	DORN, GERALD W.	reporter.nih.gov
Investigating axonal length-dependent pathology in a human stem cell-based model of Charcot-Marie-Tooth disease (type 2D)	NIH	National Institute of Neurological Disorders and Stroke	2025	$77,752	September 1, 2025	August 31, 2028	MCCLOSKEY, MOLLY CATHERINE	reporter.nih.gov
Investigating the pathomechanisms underlying Charcot-Marie-Tooth Disease	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$70,446	July 1, 2022	June 30, 2024	JONES, JULIA ALEXIS	reporter.nih.gov
YAP/TAZ in Schwann Cells as Potential Therapeutic Targets in CMT1A and HNPP.	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$65,619	August 1, 2022	July 31, 2024	MOORE, SETH MICHAEL	reporter.nih.gov
Investigating the Role of the Helicase, IGHMBP2, and the RIG-I-Like Receptor Pathway in Spinal Muscular Atrophy with Respiratory Distress Type 1 and Neuromuscular Development (SMARD1)	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$62,446	August 1, 2022	July 31, 2024	HOLBROOK, SARAH	reporter.nih.gov
Investigating the Contribution of Motor Neuronal Mitochondria to Charcot Marie Tooth Type 2D (CMT2D)	NIH	National Institute of Neurological Disorders and Stroke	2025	$45,726	August 1, 2025	July 31, 2027	FUNKE, JONATHAN	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
Scripps Research Institute, the	La Jolla, CA	6	$6.3 million	$0
Baylor College of Medicine	Houston, TX	1	$4.1 million	$0
Mitochondria in Motion, Inc.	Saint Louis, MO	3	$4 million	$0
Jackson Laboratory	Bar Harbor, ME	6	$3.9 million	$0
University of Rochester	Rochester, NY	1	$3.7 million	$0
University of Miami School of Medicine	Coral Gables, FL	3	$3.1 million	$0
University of Missouri-Columbia	Columbia, MO	3	$3 million	$0
New York University School of Medicine	New York, NY	2	$2.9 million	$0
Johns Hopkins University	Baltimore, MD	4	$2.5 million	$0
University of California Los Angeles	Los Angeles, CA	1	$2.2 million	$0
Vanderbilt University	Nashville, TN	2	$2.1 million	$0
University of California, San Francisco	San Francisco, CA	2	$2 million	$0
J. David Gladstone Institutes	San Francisco, CA	1	$1.6 million	$0
SUNY at Buffalo	Amherst, NY	2	$1.6 million	$0
University of Virginia	Charlottesville, VA	3	$1.6 million	$0
University of Southern California	Los Angeles, CA	1	$1.4 million	$0
University of Alabama at Birmingham	Birmingham, AL	1	$1.3 million	$0
Albany Medical College	Albany, NY	2	$1.2 million	$0
Ohio State University	Columbus, OH	2	$932,577	$0
Methodist Hospital Research Institute	Houston, TX	1	$804,961	$0
University of Kansas Center for Research Inc	Lawrence, KS	1	$751,688	$0
University of Miami	Coral Gables, FL	1	$705,371	$0
Wayne State University	Detroit, MI	2	$671,885	$0
Northwestern University at Chicago	Chicago, IL	1	$633,556	$0
Ut Southwestern Medical Center	Dallas, TX	1	$451,000	$0
Board of Trustees of Illinois State University	Normal, IL	1	$442,936	$0
University of Wisconsin-Madison	Madison, WI	1	$400,985	$0
Mayo Clinic Rochester	Rochester, MN	1	$363,713	$0
Neucore Bio, Inc.	Columbus, OH	1	$350,000	$0
Shift Pharmaceuticals Holdings, Inc.	Columbia, MO	1	$256,580	$0
Children's Hospital of Los Angeles	Los Angeles, CA	1	$186,250	$0
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	1	$144,326	$0
Texas Tech University Health Scis Center	Lubbock, TX	1	$136,941	$0
Salk Institute for Biological Studies	La Jolla, CA	1	$136,192	$0
University of Washington	Seattle, WA	1	$77,752	$0
Tufts University Boston	Boston, MA	1	$45,726	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	22	$9,296,804	$0
2024	24	$9,030,950	$0
2023	32	$11,842,879	$0
2022	34	$12,577,858	$0
2021	33	$13,317,790	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Functional Target Validation for Alzheimer's Disease-Related Dementias	RFA-NS-26-034	NIH	93.853	November 6, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)	PAR-27-007	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)	RFA-NS-26-001	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)	RFA-NS-26-030	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)	PAR-25-369	NIH	93.853	November 18, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)	PAR-25-371	NIH	93.853	November 18, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)	PAR-25-052	NIH	93.853	November 19, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)	RFA-AT-25-003	NIH	93.853	November 23, 2026	$375,000	Same assistance listing 93.853 as 47 awards here
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)	RFA-OD-27-008	NIH	93.853	December 2, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Required)	PAR-24-295	NIH	93.853	December 3, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)	PAR-24-296	NIH	93.853	December 3, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)	RFA-OD-24-011	NIH	93.853	December 4, 2026	Not listed	Same assistance listing 93.853 as 47 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	PAR-24-214	NIH	93.853	January 7, 2027	$375,000	Same assistance listing 93.853 as 47 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)	RFA-NS-25-023	NIH	93.853	January 15, 2027	$350,000	Same assistance listing 93.853 as 47 awards here
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)	RFA-DA-28-011	NIH	93.853	January 26, 2027	Not listed	Same assistance listing 93.853 as 47 awards here
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)	RFA-DA-28-012	NIH	93.853	January 26, 2027	Not listed	Same assistance listing 93.853 as 47 awards here
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)	PAR-24-268	NIH	93.853	January 27, 2027	$500,000	Same assistance listing 93.853 as 47 awards here
Translational Neural Devices (R61/R33 - Clinical Trial Optional)	PAR-25-053	NIH	93.853	January 28, 2027	Not listed	Same assistance listing 93.853 as 47 awards here
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)	RFA-NS-24-031	NIH	93.853	January 28, 2027	$750,000	Same assistance listing 93.853 as 47 awards here
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System	RFA-NS-28-006	NIH	93.853	January 28, 2027	Not listed	Same assistance listing 93.853 as 47 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.